Benchmark Financial Wealth Advisors, LLC

Position in AMGN — Amgen Inc

CIK 1757706 BOCA RATON, FL

Position in AMGN

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$652,178

+$9,349 QoQ

Shares Held

1,801

-1.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.52%

of 13F equity value

Holder Rank

#1,997

of 3,140 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Benchmark Financial Wealth Advisors, LLC holds $6,259,679 across 8 Drug Manufacturers - General names. AMGN ranks #5 (10.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	26,443	$1,523,645
2	LLY	ELI LILLY & Co	976	$1,170,643
3	MRK	Merck & Co., Inc.	7,860	$1,010,010
4	ABBV	AbbVie Inc.	3,881	$976,614
5	AMGN	Amgen Inc This page	1,801	$652,178
6	PFE	Pfizer Inc	14,858	$357,780
7	JNJ	Johnson & Johnson	1,211	$307,557
8	NVS	Novartis AG	1,667	$261,252

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$652,178	1,801	-1.4%	Shares	Sole	2026-07-17
2026-03-31	$642,829	1,827	+37.3%	Shares	Sole	2026-04-27
2025-12-31	$435,649	1,331	+55.7%	Shares	Sole	2026-01-27
2025-09-30	$241,281	855	-5.5%	Shares	Sole	2025-10-22
2025-06-30	$252,685	905	+17.1%	Shares	Sole	2025-08-05
2025-03-31	$240,828	773	+0.4%	Shares	Sole	2025-04-25
2024-12-31	$200,692	770	-33.7%	Shares	Sole	2025-01-27
2024-09-30	$374,408	1,162	-2.9%	Shares	Sole	2024-10-30
2024-06-30	$374,002	1,197	-11.4%	Shares	Sole	2024-07-23
2024-03-31	$384,116	1,351	+18.9%	Shares	Sole	2024-04-22
2023-12-31	$327,190	1,136	+11.7%	Shares	Sole	2024-01-23
2023-09-30	$273,328	1,017	—	Shares	Sole	2023-10-13
No filing history on record for this holder in this stock.